Clinical Trials Directory

Trials / Completed

CompletedNCT01801527

Telehealth System to Improve Quality of Life in Breast Cancer Survivors

E-Cuidate: Effectiveness of a Telerehabilitation System in Women Breast Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Universidad de Granada · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Background: Cancer is increasingly viewed as a chronic disease and therefore there is a growing need for long-term treatments. Breast cancer survivors suffer physical impairment after oncology treatment. This impairment reduces quality of life (QoL) and increases the prevalence of conditions associated to unhealthy life-style. Objective: The overall objective of e-Cuidate telerehabilitation will be to evaluate short and long-term effects telehealth program. Methods: Seventy-two breast cancer survivors (age range: 18-65 years) will be recruited through oncology and breast units at the Virgen de las Nieves Hospital and San Cecilio Hospital and associations of breast cancer patients in Granada. Patients will be randomized to receive the online rehabilitation group (n=36) or usual care (control) group (n=36). Telerehabilitation group will receive an eight-week online intervention and control group receive recommendations about usual care. Discussion: The investigators study attempts to increase the level of fitness and reduce musculoskeletal disorders in breast cancer patients through a strategy for care based on telerehabilitation to promote therapeutic exercise.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTelerehabilitation groupInterventions will be based on to provide cardiovascular, mobility, strength and stretching exercises through telerehabilitation system

Timeline

Start date
2012-03-01
Primary completion
2014-02-01
Completion
2014-07-01
First posted
2013-02-28
Last updated
2017-10-27

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01801527. Inclusion in this directory is not an endorsement.